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At present, there s t i l l exists certain reservation concerning digitalis glyco-
sides treatment of decompensated cor pulmonale. Th i s reservation is based mainly 
on the known unwanted hemodynamic effect of glycosides related to the increase 
of pulmonary arterial pressure and to a less extent — of pulmonary vascular re-
sistance (1—5). 
Some authors contrast the r isk of rapid advancing digitalis intoxication 
induced by progressed respiratory insufficiency wi th the increased myocardial 
contract i l i ty by digitalis giycosides (6—8). 
T h e determination of the serum levels of cardiac glycosides wi th small cu-
mulative effect such as of digoxin enables a more profound evaluation of the side 
effects and r isk from overdosage. 
The purpose of the present work consists in : 
I . Es t imat ion of serum digoxin levels in case of moderately rapid and slow 
saturation during advanced respiratory and right-side heart insufficiency. 
2. Ascertaining of the maximal levels of serum digoxin and of c l in ica l symp-
toms of toxic doses. 
3. Follow-up of the risk factors of the digitalis intoxication. 
Material and methods 
A total of 35 patients (32 males and 3 females) at an average age of 5 9 = 8 
years wi th chronic obstructive lung disease ( C O L D ) and chronic cor pulmonale 
at the stage of decompensation were studied. A t ly ing position, serum levels of 
digoxin, potassium, sodium, calcium and chlorides were estimated prior to digo-
x i n therapy as wel l as on the 1st, 5th and 10th day after beginning of treatment. 
Serum levels were assessed on the 5th and on the 10th day 8 hours after the last 
taking of the drug. A l l the patients were administered the rest adequate therapy 
including chemotherapeutics, bronchodilatators, and mucolytics. Diuretics were 
commonly administered intermittently observing the rule to exclude aldosterone 
antagonists. C l in ica l characteristics was based on the physical , functional, roent-
genological, and electrocardiographical examination as well as on the follow-up 
of both objective and subjective symptomatics of digitalis preparation overdo-
sage. Patients were divided into 3 groups in the course of treatment and investi-
gation: 1 s t group of 19 patients treated wi th digoxin (Richter , G D R ) at dosis of 
1 tablet thrice dai ly for 5 days up to total dosis of 3.75 mg followed by main-
tenance dosage of one tablet (a dosis of 0.25 mg) dai ly. 2 n d group consisted in 8 
patients in which a maintenance dosage was started. Blood gases were examined 
at the onset as well as on the 10 t h day after beginning of treatment. I n the 3 r d 
group consisting in 8 patients wi th chronic respiratory failure and cor pulmonale 
maintenance dosage of one digoxin tablet dai ly was of 3 month duration prior 
to investigation. 
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T a b l e 1 
Serum d i g o x i n levels ( S D L ) 
Indexes 
Patients'groups 
first second third 
before th th before 5 t h 5 t h th 3 r d treatment 5 day 10 day treatment hour day 10 day month 
0.99== 3 . 0 2 ± 2.51=1= 0.19==: 0.68=1= 1.1=1= 2.14=1= 1.56== 
0.56 1.35 1.46 0.07 0.09 0.21 0.25 0.39 
146=s=ll 146:== 9 143=1=13 136=1=8 — 133=1=5 — 
4.76=!= 4.99=1= 4.44==: 4.86=1= 4.78=1= 
0.23 0.19 0.36 0.68 0.74 
106== 18 119=±=24 114=1=21 101=±= 11 — — 105=1=13 — 
2.44== 2.62=1= 2.39=1= — — — — — 
0.31 0.56 0.33 
104^=8 102=1=11 103=1=9 — — — — — 




























We considered reference values of therapeutic digoxin concentrations for 
adults these given by the firm between 1.5 and 1.8 nmol/1 but toxic ones — over 
2,6 nmol/1. 
Results and discussion 
Digoxin levels were studied after a 5-day interrution in order to achieve 
disappearance of its effect in the patients of the first group. The serum concentra-
tions (presented on table 1) — 0.99===0.56 nmol/1 — showed that excretion was 
delayed despite the absence of renal failure. Digoxin administration at a dosis 
of 0.75 mg dai ly for 5 days elevated the concentrations up to 3.02=+= 1.35 nmol/1. 
I n two patients wi th chronic pulmonary failure, 1 s t stage, the levels reached up 
to 5 nmol/1 without any electrolyte changes. Electrocardiographically, 6 patients 
demonstrated diffuse S T - T changes due to digitalis but one patient — due to 
sinusoidal bradycardia. Maintenance dosage administration during the next 
5 days resulted in serum digoxin level reduction down to 2.51 =+=1.46 nmol/1. Heart 
frequency decreased stat ist ically significantly (p<0.001) on the 5 t h day as compar-
ed wi th that of the in i t ia l rate and then increased insignificantly on the 10 t h 
day after beginning of the study (fig. 1). 
Patients of the 2 n d group had not received digoxin 3 months long before treat-
ment and investigation. I t was confirmed by the levels established prior to inve-
s t i ga t i on—namely 0.19=r=0.07 nmol/1. F i v e hours after the first taking of the 
drug a considerable change of serum digoxin level occurred — 0.68=±=0.09 nmol/1 
reaching up to 1.1 =±=0.21 nmol/1, i . e. nearly to the therapeutic one on the 5 t h day 
but then insignificantly prevail ing over it on the 10 t h day (2.14=±=0.25 nmol/1) 
(fig. 2) . The rates of partial pressure of C 0 2 — p C 0 2 and of oxygen — p 0 2 were 
prior to treatment 8.64=== 1.57 k P a (67=== 12 mm Hg) and 7.42=±=0.1 k P a (56===0.8 
mm H g ) , respectively. Therefore, we considered the respiratory failure an ad-
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vanced one. After a 10-day treatment both hypoxemia and hypercapny persisted 
but they were considerably reduced down to the following rates: p0 9 —8.21 ± 0 . 2 1 
k P a ( 6 2 ± 1 . 6 mm Hg) and p C 0 2 — 7.01 ± 0 . 9 6 k P a ( 5 3 ^ 7 . 2 mm Hg) . Concerning 
the patients of the 3 r d group who were on maintenance therapy for more than 3 
U I I 
О 5ibday Wtrrdag 
F i g . 1. 
months prior to study it could be noted that stabile therapeutic concentrations 
(1.56=±:0.39 nmol/1) were warranted (fig. 3) . 
We established high residual levels inspite of 5-day long digoxin therapy 
interruption. When we related this fact to the early therapeutic levels during 
maintenance treatment of the patients of the 2 n d group we could realize that di­
goxin resorption was much higher than the presumed one but excretion quota 
was lower, on the contrary. The absence of severe phenomena of digitalis intoxi­
cation made rather doubtful the known fact that myocardium was more sensible 
in hypoxemic patients. P . Souich and J . P . Clozel (9) proved that hypoxemia 
prolonged plasma half-life of digoxin from 25 up to 33 hours but digoxin concen­
trations increased in the brain and diaphragm musculature and did not in the 
heart muscle despite high serum levels. A . Nanj i i and D . Greenway (10) rendered 
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count of the presence of digoxin-like immuno-reactive substances in hepatic and 
nal lesions as well as in premature newborns. 
0 
70 t h day 
5 t h ftour 6 t h day 10 th'day 6,ra'month 
F i g . 3. 
The lack of any digitalis intoxication inspite of the high digoxin levels should 
be explained by the absence of electrolyte disturbances in our patients. L . Green 
and T . Smi th (11) point out that hypokaliemia and renal lesions cause digital is 
intoxication in 53 per cent of cor pulmonale patients. J . Morrison and T . K i l l i p 
(12) find out a digitalis intoxication at 1.2 ng/ml in 8 patients wi th p 0 2 of 39 mm 
H g . G . Koren and R. Parker (13) investigate 47 children aged between 2 and 16 
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years and emphasize that the very high serum digoxin concentrations exert not 
always a toxic effect. R . Goldmann and D . Harrison (14) report that while hypo-
xemia possesses an indirect effect hypercapny acts directly on sympathico-adrenal 
st imulation. The fact that we have not investigated blood-gas parameters in most 
of our patients does not enable us to associate ourselves wi th this concept, s t i l l 
more, that heart frequency reduction is best experessed in cases wi th the highest 
serum digoxin concentration. 
We can draw the following conclusions: 
1. Digoxin has a good enteral resorption in patients wi th chronic respiratory 
insufficiency and cor pulmonale. 
2. Both^ moderately rapid saturation and continuous maintenance therapy 
together wi th missing electrolyte balance disturbances does not create any r isk 
of intoxication. 
3. Excessive elevation of serum digoxin levels is c l in ica l ly manifested as a 
bradycardic effect and ST-T-changes of the electrocardiogram. 
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СЫВОРОТОЧНЫЕ (КОНЦЕНТРАЦИИ ДИГОКСИНА ПРИ [ЛЕЧЕНИИ 
ХРОНИЧЕСКОГО ЛЕГОЧНОГО СЕРДЦА . 
X. Цеков, Б. Каназирев, Т. Русева 
I 
Р Е З Ю М Е ! 
I 
При помощи радиоиммунологической методики прослеживался сывороточный уровень 
дигоксина у 35 больных хронической обструктивной легочной болезнью и хроническим ле­
гочным сердцем. Установлено, что умеренно быстрое насыщение и непрерывное поддержи­
вающее лечение не создают риска интоксикации. Эксцессивно повышенный уровень дигок­
сина вызвал брадикардию у одного больного. У шести больных наблюдались S T - T изме­
нения дигиталисового типа. Получение терапевтических сыровоточных концентраций к 
пятому дню умеренно быстрого насыщения (3.02—1.35 нмол/л) и к десятому дню (2.14=^0.25 
нмол/л) свидетельствует о хорошей энтеральной резорбции дигоксина. Умерено быстрое 
насыщение статистически достоверно замедляет сердечную деятельность ( Р < 0 . 0 0 1 ) . Н и з к и й 
исходный уровень, установленный у больных, не получающих дигоксина до исследования 
(0 .19^0.07 нмол/л), доказывает отсутствие дигоксиноподобных субстанций и определяет 
высокую специфичность радиоиммунологического метода. Определение сывороточных кон­
центраций дигоксина дает представлението некоторых особенностях его фармакокинетики . 
Это подчеркивает также, что страх интоксикации дигиталисом у больных хронической об­
структивной легочной болезнью и хроническим легочным сердцем неоснователен. 
